Navigation Links
Filtrona Fibertec Ningbo, China Plant Celebrates Expansion
Date:10/2/2007

RICHMOND, Va., Oct. 2 /PRNewswire/ -- Filtrona Fibertec, a division of Filtrona plc, developer of fiber-based capillary technology and manufacturer of custom fluid handling components, celebrated the completion of the recent expansion of its plant in Ningbo, China with a Grand Opening celebration.

(Logo: http://www.newscom.com/cgi-bin/prnh/20061127/DCM011LOGO )

The expansion includes an increase of more than double the size of production floor space and an expanded analytical laboratory to support the technical service needs of the regional customer base. The plant is located in Ningbo (Zhejiang Province near Shanghai) and its first phase was completed in 2005. Construction for the expansion commenced in late 2006 and was complete by mid 2007.

Filtrona Fibertec designs, develops, and manufactures bonded fiber fluid control components serving a variety of industrial and consumer markets including writing instruments, medical diagnostics, inkjet printing systems, and household products.

The Grand Opening celebration was well attended by customers, high level dignitaries from both government and business, and the company's senior executives, including Filtrona plc Chief Executive Mark Harper and Filtrona Fibertec President Russ Rogers. Highlights of the celebration included speeches by the Ningbo Economic Technical Development group and Filtrona management, followed by the traditional ribbon cutting ceremony and fireworks display.

With the phase one manufacturing space already near full utilization, this expansion provides needed room for Filtrona Fibertec's regional growth and for two other divisions of Filtrona plc -- Filtrona Extrusions and Moss Plastic Parts. "The Filtrona Fibertec expansion provides the infrastructure and support services from which a number of our businesses will launch their new commercial growth efforts in China and the Asia
'/>"/>

SOURCE Filtrona Fibertec
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. China tells officials not to hide SARS damage
2. China reports declining number of SARS Cases
3. China says patient may have SARS
4. 15 Anti-SARS Drugs Identified By China-Europe Team of Researchers
5. Adverse Effects Associated with Unauthorised Hepatitis A Vaccine in China
6. Pig Bacterium (Streptococcus suis) Kills 24 In China
7. Watch Out! Pollution hazard from E-waste recycling in India & China
8. French Fries In Cancer Controversy In China
9. China To Distribute Free Condoms To Combat AIDS/HIV
10. HIV Cases Steadily Increasing In China With The Toll Over 1.26 Lakh
11. India And China Discuss Import Of Encephalitis Vaccine

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)...New book called "Preventing and Healing AIDS ...raldo shows that AIDS is a result of multiple, rep...ed immune system stressor agents, which can be eit...l, emotional. , Oakland,...; 8, 2009, cell biologists, physicians, chemists a...
(Date:11/8/2009)...A jury of 8 people in the Western District of Penn...n pain and suffering for a medical malpractice cas...icia Nocera of Thomas E. Crenney and Associates, L...ta Monestersky and against the Uniontown Hospital....al hysterectomy at age 18. , ...
(Date:11/8/2009)...PRNewswire-USNewswire/ -- USAction this evening ha...rica Act, which will make health care more afforda...table and increase access to health care for milli...eddy Roosevelt, FDR and Harry Truman would be prou...Today,s vote ranks among our country,s proudest ac...
(Date:11/8/2009)...Passage of Health Care Reform Bill ,, Critica...overage for all Americans ,, CHICAGO, Nov. 7 /... House of Representatives passed by a vote of 220-...would strengthen Medicare for seniors and end disc...ions of Americans out of affordable health coverag...
(Date:11/7/2009)...PRNewswire-USNewswire/ -- Karen Ignagni, President...), released the following statement today on House...y support comprehensive health care reform, and we...a complete overhaul of how health insurance is pro...overage, elimination of pre-existing condition exc...
Breaking Medicine News(10 mins):Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 2Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 3Health News:Pennsylvania Jury Awards $2.3 Million to Fayette County Woman in Medical Malpractice Case 2Health News:AARP Illinois Key Vote News Alert 2Health News:AARP Illinois Key Vote News Alert 3Health News:AHIP Statement on House Passage of H.R. 3962 2
...appear to curb compulsive acting out, study says ,...class of Parkinson,s disease drugs called dopamine...e behaviors such as compulsive gambling or hyperse...e and ropinirole, developed unhealthy behaviors. B...
...s to use their own words, not government forms, to...iving will is a national resource for advance care...Aging with Dignity, a national non-profit organiza...ricans to complete an advance directive on Nationa...
...lty suggests that a gene associated with onset of ...ase dementia cases. The research, led by Dr. Giuli...Professor in Neurology, and Professor of Psychiatr..., "This new evidence is of extreme interest," Dr....
...Dublin published in this month,s Annals of Surger...the treatment of patients undergoing major cancer ...eal research group at Trinity College Dublin and S...ion of muscle mass in patients undergoing surgery ...
...times a scientific article is cited by other artic... impact, online publishing offers another measure:...ysis in the online Journal of Vision finds that ... Vision (JOV) Editor-in-Chief Andrew Watson. (htt...
...old question, , , FRIDAY, April 10 (Health...has been going on for years. But with the U.S. eco...estion -- how old is too old to work? -- has becom...arket tumbles, they joke that they,ll have no choi...
Other Medicine News:Health News:Parkinson's Drugs Can Trigger Unhealthy Behaviors 2Health News:Aging with Dignity Celebrates National Healthcare Decisions Day 2Health News:Mount Sinai researchers discover novel mechanisms that might causally link type-2 diabetes to Alzheimer's disease 2Health News:Omega-3 fatty acids may benefit cancer patients undergoing major operations 2Health News:Omega-3 fatty acids may benefit cancer patients undergoing major operations 3Health News:Omega-3 fatty acids may benefit cancer patients undergoing major operations 4Health News:How Old Is Too Old to Work? 2Health News:How Old Is Too Old to Work? 3
(Date:11/6/2009)...wswire-FirstCall/ -- Oxygen Biotherapeutics, Inc. ...previously approved reverse split of its common st...nday, Nov. 9, 2009 on a 1-for-15 split-adjusted ba...e under the new symbol OXBT. The stock also will h...t becomes effective. ,, "This reverse split was...
(Date:11/6/2009)... Pa., Nov. 6 In consultation with ...l Consumer Healthcare, Division of McNEIL-PPC, Inc...umber of product lots of TYLENOL® Arthritis P... red EZ-OPEN CAP. McNeil is initiating the recall ...te associated with these lots that led to a small ...
(Date:11/6/2009)...ire/ -- Trius Therapeutics, Inc. announced today t...S-1 with the U.S. Securities and Exchange Commissi...ering of shares of its common stock. All shares of...be offered by the Company. ,, Credit Suisse Sec...anager, Piper Jaffray & Co. is acting as co-le...
Breaking Medicine Technology:Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 2Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 3McNeil Consumer Healthcare Announces Voluntary Recall of Certain Lots of TYLENOL(R) Arthritis Pain 100 Count with EZ-OPEN CAP 2Startech Environmental Advises Shareholders to Take No Action in Response to Friendly LRL Tender Offer 50901 1Startech Environmental Advises Shareholders to Take No Action in Response to Friendly LRL Tender Offer 50901 2Startech Environmental Advises Shareholders to Take No Action in Response to Friendly LRL Tender Offer 50901 3HMS Awarded Third Party Data Match and Recovery Contract by Mississippi Medicaid 50897 1Fortune Recognizes Female Health Company as One of Americas Fastest Growing Small Companies 50895 1Fortune Recognizes Female Health Company as One of Americas Fastest Growing Small Companies 50895 2Fortune Recognizes Female Health Company as One of Americas Fastest Growing Small Companies 50895 3Fortune Recognizes Female Health Company as One of Americas Fastest Growing Small Companies 50895 4
...IANAPOLIS, Sept. 20 Eli Lilly and Company,(NYSE: ...plication with the,European Medicines Agency (EMEA...for injection), in combination with cisplatin, for...ll lung cancer (NSCLC). ALIMTA is currently indic...ingle agent for the treatment of patients with loc...
...When compared to insulin glargine, exenatide offer...ta-cell function when used with metformin --, AMS...als, Inc. (Nasdaq: AMLN ) and Eli Lilly and Compa...paring treatment of exenatide injection,with insul...l and weight in,people with type 2 diabetes. Study...
Other Medicine Technology:Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer 2Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer 3Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer 4Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer 5Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer 6Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer 7Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer 8Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer 9Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer 10Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer 11Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer 12One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 2One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 3One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 4One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 5One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 6One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 7
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
Medicine Products: